AnalysisNews

BNGO today

$1.10-$0.13 (-10.57%)close Nov 11, 2026

Trend

DailyUptrend (starting)

4 hourStrong Bearish

1 hourAscending Triangle

15 minExpanding

5 minDescending Triangle

Daily trend turns down below $1.00

Key levels

Resistance$1.25

Resistance$1.12

Support$1.00

Latest news & SEC filings

EarningsBionano Genomics Posts Q3 2026 Results

EarningsBionano Genomics hosts quarterly results call for Q3 2026

EarningsBionano Genomics posts wider quarterly loss and lower revenue than expected

EarningsBionano Genomics posts $8.276M in quarterly revenue, under estimate

All BNGO news →

About Bionano Genomics

Bionano Genomics provides genome analysis solutions built around optical genome mapping, which detects structural variations in DNA. It develops and sells the Saphyr and Stratys mapping systems, the Ionic nucleic acid purification platform, and VIA software for interpreting genomic data. Through its Bionano Laboratories subsidiary, it offers diagnostic testing services, including a test for a form of muscular dystrophy affecting the face, shoulders, arms and legs. Its customers include clinical and research labs, universities, government bodies, and drugmakers, served from facilities in San Diego and partner sites in the United States and Europe.

Based on the company's 10-K filed Mar 23, 2026.

Nasdaq · Technology

Bionano Genomics, Inc. (BNGO)

$1.10-0.13 (-10.57%)
WATCHLISTGrade: C+Risk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
1.191.291.381.481.10Oct 9Oct 19Oct 27Nov 4
High1.30
Low1.09
Open1.17
Volume544K
Avg Vol214K
VWAP1.13
30d High1.57
30d Low1.10
30d Chg-29.94%

What Is the Price Target for BNGO?

SEPT Low Target

$6.00

SEPT Mid Target

$6.00

SEPT High Target

$6.00

Analyst Consensus

$6.00

Current: $1.14Upside: +426.3%Confidence: 40%Method: Analyst Consensus

Is BNGO a Buy or Sell Right Now?

52
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing -7.4% YoY with SLOWING trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BNGO.

Start Free Trial →

Is BNGO Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$6.47

11

Moat Score

NONE

4/9

Piotroski Score

-14.3

Altman Z-Score

What Is Smart Money Doing with BNGO?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Adamchak MarkofficerSale7$9.10Jun 3, 2026
Dixon Jonathan V.officerSale24$31.20Jun 3, 2026
Chaubey AlkaofficerSale24$31.20Jun 3, 2026
OLDAKOWSKI MARKofficerSale27$35.10Jun 3, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

BNGO Growth Story

Revenue YoY

-7.4%

3yr Revenue CAGR

0.8%

EPS Growth YoY

94.5%

FCF Growth YoY

N/A%

Revenue Trend

SLOWING

Dark Pool Trades for BNGO

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for BNGO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:37:11$1.1512,891$$15KBUY
21:35:46$1.152,346$$3KBUY
21:34:59$1.133,423$$4KBUY
21:33:36$1.131,712$$2KBUY
21:04:32$1.121,000$$1KBUY

5 dark pool trades shown · $$24K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Bionano Genomics, Inc. (BNGO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

BNGO — frequently asked questions

What is BNGO stock price today?

Bionano Genomics, Inc. (BNGO) is at $1.10, down 10.57% (-$0.13) at the Nov 11, 2026 close.

Why is BNGO stock moving today?

Latest BNGO news — Nov 11, 2026: Bionano Genomics Posts Q3 2026 Results · Nov 10, 2026: Bionano Genomics hosts quarterly results call for Q3 2026

What is the BNGO price target?

The average analyst price target for BNGO is $6.00, ranging from $6 to $6, based on 1 analysts. Latest: HC Wainwright & Co. maintains on Apr 13, 2026.

What do analysts rate BNGO?

Analyst ratings for BNGO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.

Did BNGO beat earnings?

BNGO last reported on Aug 10, 2026: EPS -$0.64 vs -$0.67 expected — a beat of 4.5%.

Does BNGO pay a dividend?

BNGO does not currently pay a dividend.

What are BNGO support and resistance levels?

Support: $1.00. Resistance: $1.12, $1.25, $1.35.

What are insiders doing with BNGO?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on BNGO?

Nov 11, 2026: Bionano Genomics Posts Q3 2026 Results · Nov 10, 2026: Bionano Genomics hosts quarterly results call for Q3 2026 · Nov 10, 2026: Bionano Genomics posts wider quarterly loss and lower revenue than expected